Strasbaugh Receives Multi-Million Dollar Order for its New STB P300 CMP System.

Strasbaugh (OTC Bulletin Board: STRB) announced today that it has received a multi-million dollar order for its new STB P300 CMP system. The order follows the recent introduction of the product at Semicon West 2009. The tool was purchased by a U.S. customer.

"Device makers are telling us they need a new generation CMP system that not only improves their process performance, but has the design and features that will enable them to realize the efficiencies of lean and flexible manufacturing. This order confirms the P300 delivers the benefits they are looking for," said Chuck Schillings, Strasbaugh's President and CEO.

The P300 combines the greatest production and process flexibility of any CMP machine on the market with the most advanced CMP technologies available, including Strasbaugh's revolutionary new nVision II(TM) optical endpoint detection system, next generation Saturn(TM) wafer carrier, ultra Precision(TM) pad conditioner, and industry-proven integrated cleaning.

Strasbaugh has 60 years of leadership in design and manufacturing of advanced surfacing technology for the global semiconductor, silicon, data storage, MEMS, LED, telecommunications and optics industries. Through close alliances with premier manufacturers in these markets, Strasbaugh has developed pioneering technology that has become the standard in polishing and grinding today. Strasbaugh's state-of-the-art chemical mechanical planarization (CMP) systems, high quality prime wafer polishing and grinding tools, and leading edge process technologies, enable customers to realize their performance goals and has established the company as a world class provider of innovative, reliable, high-yield surfacing solutions.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.